Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK) Fell 2.25%, with the Latest Price at HKD 13.440
Newtimespace News:As of 09:44 on May 26, the Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK)fell 2.25%, with the latest price at HKD 13.440, a high of HKD 13.750, a low of HKD 13.440, an average price of HKD 13.572, assets under management of approximately HKD 2.134 billion, a latest net asset value of HKD 13.750, and a discount of 0.09%.
The Chinaamc Hang Seng Hong Kong Biotech Index ETF (03069.HK)tracks the Hang Seng Biotech Index, which consists of listed companies in biotech, pharmaceuticals, and healthcare sectors in Hong Kong, reflecting the overall performance of Hong Kong's biotech sector.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- KNOWLEDGE ATLAS(02513.HK) closed 19.29% lower, closing at HKD 1640
- TAN CHONG INT'L (00693.HK): Expected Unrealised Investment Loss of HK$512 Million for First Half Due to Share Price Movements of Listed Investments
- SBP GROUP (01177.HK): NDA Accepted for Category 1 Innovative Drug IDH1 Inhibitor TQB3454 for Advanced Biliary Tract Cancer
- Pizu Group(09893.HK): Change of Independent Non-executive Director, Appointment of Wei Lai
- DUFU LIQUOR GP (00986.HK): Li Jingfu Appointed CEO of Subsidiary to Lead Research on AI Digital Human and Internet Marketing Business